Study Stopped
failure to recruit
Structural and Functional Brain Reorganization in Neuropathic Pain: Basal State of Local Cerebral Blood Flow and Functional Connectivity
CONNECT
2 other identifiers
interventional
68
1 country
1
Brief Summary
Neuropathic pain is a medical condition involving allodynia (painful perceptions in response to stimuli that normally are not) and spontaneous pain (occurring at rest, without stimulation). This pain is secondary to nervous system injury affecting the sensory system. The lesion is either at the nerve endings of the spinal cord or brain. It induces a loss of sensitivity and likely reorganization of brain activity that are causing pain and which are the subject of this study. Previous studies in functional neuroimaging has focused on brain areas activated during allodynic stimuli compared to non-painful stimuli. The abnormalities have been reported, but it was not possible to conclude formally. The authors failed to assess the part of the effect of the loss of sensory afferents (deafferentation) and the basal brain function. Indeed, the operation without any sensory stimulation is not known yet is the initial level of activity which is the benchmark for studying brain function during stimulation. The objective of this study is to understand what are the cortical systems of allodynic dysfunctional in patients compared with controls at baseline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 25, 2016
CompletedFirst Submitted
Initial submission to the registry
July 25, 2016
CompletedFirst Posted
Study publicly available on registry
August 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 22, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2019
CompletedSeptember 28, 2020
September 1, 2020
3 years
July 25, 2016
September 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
cerebral blood flow
quantified with MRI scan
at baseline
Secondary Outcomes (4)
rate of grey matter
at baseline
structure of the networks
at baseline
connection of the networks
at baseline
cortical loss
at baseline
Study Arms (3)
peripheric nervous lesion
EXPERIMENTALMRI scan
medullar or encephalic lesion
EXPERIMENTALMRI scan
control group
OTHERMRI scan
Interventions
Eligibility Criteria
You may qualify if:
- major
- with nervous pain : chronic or peripheric
- treatment not stable opioid since one week
- signed consent
- major
- without chronic pain
- signed consent
You may not qualify if:
- severe psychiatric history
- presence of an active nervous lesion
- subject with morphine treatment
- contraindication to MRI scan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de SAINT-ETIENNE
Saint-Etienne, 42000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roland PEYRON, MD
CHU de SAINT-ETIENNE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2016
First Posted
August 8, 2016
Study Start
March 25, 2016
Primary Completion
March 22, 2019
Study Completion
March 22, 2019
Last Updated
September 28, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share